Fernandez, Xyrained B.

HRN: 29-21-61  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/25/2026
CEFTRIAXONE 1G (VIAL)
06/25/2026
07/02/2026
IV
900mg
Q24
CNSI
Checking Initial Appropriateness 

 Indication:  ProphylaxisEmpiric    Type of Infection:  BloodstreamCentral Nervous SystemProphylaxis    Compliance to guidelines: Compliant To Guidelines